CRL - Company ID 0001100682
The table below shows CHARLES RIVER LABORATORIES INTERNATIONAL, INC.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $4.02B | $4.05B | $4.13B | $3.98B | $3.54B | $2.92B |
| Cost of revenue | - | - | - | - | - | - |
| Gross profit | - | - | - | - | - | - |
| R&D | - | - | - | - | - | - |
| SG&A | $743.07M |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. reported annual revenue of $4.02B for fiscal year 2025. That is down 0.9% from $4.05B in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $1.68B (FY 2016) to $4.02B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $751.00M |
| $747.86M |
| $665.10M |
| $619.92M |
| $528.93M |
| Operating income | $25.16M | $227.35M | $617.26M | $650.98M | $589.86M | $432.73M |
| Income tax | $42.66M | $67.82M | $100.91M | $130.38M | $81.87M | $81.81M |
| Net income | -$144.34M | $22.20M | $474.62M | $486.23M | $390.98M | $364.30M |
| EPS (diluted) | -$2.91 | $0.20 | $9.22 | $9.48 | $7.60 | $7.20 |